Literature DB >> 2888493

Thy-1: a lymphoid cell subset marker capable of delivering an activation signal to mouse T lymphocytes.

S Pont1.   

Abstract

Monoclonal anti-Thy-1 antibodies are capable of activating mouse T cells in the absence of an antigen-specific signal. Therefore, Thy-1 appears to be connected to an alternative signal transduction pathway, operative in thymocytes as well as in neuronal cells, since this molecule is also present on brain. Biochemical data have shown that this molecule is differentially glycosylated with respect to its cellular distribution. Structure and sequence comparisons revealed a strong homology with the immunoglobulin primordial domain. In addition, the Thy-1 glycoprotein has the particularity of being anchored to the membrane via a glycophospholipid tail. Gene transfer experiments in different cell types have been performed to analyze the mechanism of the Thy-1 pathway of activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888493     DOI: 10.1016/0300-9084(87)90022-8

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  11 in total

1.  Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV.

Authors:  Tiffany Jones; Fengchun Ye; Roble Bedolla; Yufei Huang; Jia Meng; Liwu Qian; Hongyi Pan; Fuchun Zhou; Rosalie Moody; Brent Wagner; Mazen Arar; Shou-Jiang Gao
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

2.  Live fibroblast harvest reveals surface marker shift in vitro.

Authors:  Graham G Walmsley; Yuval Rinkevich; Michael S Hu; Daniel T Montoro; David D Lo; Adrian McArdle; Zeshaan N Maan; Shane D Morrison; Dominik Duscher; Alexander J Whittam; Victor W Wong; Irving L Weissman; Geoffrey C Gurtner; Michael T Longaker
Journal:  Tissue Eng Part C Methods       Date:  2014-12-17       Impact factor: 3.056

3.  Biological heterogeneity of primary cancer-associated fibroblasts determines the breast cancer microenvironment.

Authors:  Marika Musielak; Oliwia Piwocka; Katarzyna Kulcenty; Karolina Ampuła; Beata Adamczyk; Igor Piotrowski; Magdalena Fundowicz; Marta Kruszyna-Mochalska; Wiktoria M Suchorska; Julian Malicki
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 4.  Multiple roles of CD90 in cancer.

Authors:  Atul Kumar; Anshuman Bhanja; Jina Bhattacharyya; Bithiah Grace Jaganathan
Journal:  Tumour Biol       Date:  2016-06-23

5.  The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro.

Authors:  L J Jenski; J M Scherer; L D Caldwell; V A Ney; W Stillwell
Journal:  Lipids       Date:  1998-09       Impact factor: 1.880

6.  Markers for characterization of bone marrow multipotential stromal cells.

Authors:  Sally A Boxall; Elena Jones
Journal:  Stem Cells Int       Date:  2012-05-14       Impact factor: 5.443

7.  Impaired specific CD8 T cell response with aging is not due to decreased expression of CD90 on TCR transgenic T cells.

Authors:  Jiu Jiang; Erin Fisher; Donna M Murasko
Journal:  Immun Ageing       Date:  2013-08-19       Impact factor: 6.400

8.  Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response.

Authors:  Suzanne Furlong; Melanie R Power Coombs; Javad Ghassemi-Rad; David W Hoskin
Journal:  Front Cell Dev Biol       Date:  2018-11-23

9.  CD49b, CD87, and CD95 Are Markers for Activated Cancer-Associated Fibroblasts Whereas CD39 Marks Quiescent Normal Fibroblasts in Murine Tumor Models.

Authors:  David J Agorku; Anne Langhammer; Ute Heider; Stefan Wild; Andreas Bosio; Olaf Hardt
Journal:  Front Oncol       Date:  2019-08-05       Impact factor: 6.244

10.  CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias.

Authors:  Xiucong Pei; Jianhui Zhu; Rui Yang; Zhijing Tan; Mingrui An; Jiaqi Shi; David M Lubman
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.